Gastroenterology
Volume 129, Issue 2 , Pages 415-421 , August 2005

Cancer Risk in Hereditary Nonpolyposis Colorectal Cancer Syndrome: Later Age of Onset

  • Heather Hampel

      Affiliations

    • Human Cancer Genetics Program, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA
    • ,
  • Julie A. Stephens

      Affiliations

    • Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA
    • ,
  • Eero Pukkala

      Affiliations

    • Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
    • ,
  • Risto Sankila

      Affiliations

    • Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
    • ,
  • Lauri A. Aaltonen

      Affiliations

    • Department of Medical Genetics, University of Helsinki, Helsinki, Finland
    • ,
  • Jukka-Pekka Mecklin

      Affiliations

    • Department of Surgery, Keski-Suomi Central Hospital, Jyvaskyla, Finland
    • ,
  • Albert de la Chapelle

      Affiliations

    • Human Cancer Genetics Program, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA
    • Corresponding Author InformationAddress requests for reprints to: Albert de la Chapelle, MD, PhD, The Ohio State University, Human Cancer Genetics Program, 420 West 12th Avenue, Columbus, Ohio 43210. fax: (614) 688-4772.

Received 16 February 2005 ,Accepted 27 April 2005.

References 

  1. Vasen H, Wijnen J, Menko F, Kleibeuker J, Taal B, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis . Gastroenterology . 1996;110:1020–1028
  2. Mecklin J , Jarvinen H . Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer) . Cancer . 1991;68:1109–1112
  3. Lynch H, Smyrk T, Watson P, Lanspa S, Lynch J, Lynch P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer (an updated review) . Gastroenterology . 1993;104:1535–1549
  4. Vasen H , Mecklin J-P , Khan P , Lynch H . The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer . Dis Colon Rectum . 1991;34:424–425
  5. Vasen H , Watson P , Mecklin J-P , Lynch H . New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC . Gastroenterology . 1999;116:1453–1456
  6. Rodriguez-Bigas M, Boland C, Hamilton S, Henson D, Jass J, Khan P, et al. National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome (meeting highlights and Bethesda guidelines) . J Natl Cancer Inst . 1997;89:1758–1762
  7. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability . J Natl Cancer Inst . 2004;96:261–268
  8. Satagopan J, Boyd J, Kauff N, Robson M, Scheuer L, Narod S, et al. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations . Clin Cancer Res . 2002;8:3776–3781
  9. Satagopan J, Offit K, Foulkes W, Robson M, Wacholder S, Eng C, et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations . Cancer Epidemiol Biomarkers Prev . 2001;10:467–473
  10. Begg C . On the use of familial aggregation in population-based case probands for calculating penetrance . J Natl Cancer Inst . 2002;94:1221–1226
  11. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families . Am J Hum Genet . 1998;62:676–689
  12. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews . N Engl J Med . 1997;336:1401–1408
  13. Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutation . Lancet . 1998;352:1337–1339
  14. King M , Marks J , Mandell J , Group NYBCS . Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 . Science . 2003;302:643–646
  15. Mecklin J , Jarvinen H . Clinical features of colorectal carcinoma in cancer family syndrome . Dis Colon Rectum . 1986;29:60–64
  16. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes . Int J Cancer . 1999;81:214–218
  17. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease . N Engl J Med . 1998;338:1481–1487
  18. Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer . J Clin Oncol . 2000;18:2193–2200
  19. Chase G , Folstein M , Breitner J , Beaty T , Self S . The use of life tables and survival analysis in testing genetic hypotheses, with an application to Alzheimer’s disease . Am J Epidemiol . 1983;117:590–597
  20. Greenwood M . Reports on public health and medical subjects (the errors of sampling of the survivorship tables) . Reports on public health and statistical subjects . London: HMSO; 1926; 33:Appendix 1
  21. Brookmeyer R , Crowley J . A confidence interval for the median survival time . Biometrics . 1982;38:29–41
  22. Chung G , Rustgi A . The hereditary nonpolyposis colorectal cancer syndrome (genetics and clinical implications) . Ann Intern Med . 2003;138:560–570
  23. Lynch H, Lanspa S, Boman B, Smyrk T, Watson P, Lynch J, et al. Hereditary nonpolyposis colorectal cancer—Lynch syndromes I and II . Gastroenterol Clin North Am . 1988;17:679–712
  24. Lynch H , de la Chapelle A . Genomic medicine (hereditary colon cancer) . N Engl J Med . 2003;348:919–932
  25. DeFrancisco J , Grady W . Diagnosis and management of hereditary non-polyposis colon cancer . Gastrointest Endosc . 2003;58:390–408
  26. Parc Y , Boisson C , Thomas G , Olschwang S . Cancer risk in 348 French MSH2 or MLH1 gene carriers . J Med Genet . 2003;40:208–213
  27. Watson P , Lynch H . Cancer risk in mismatch repair gene mutation carriers . Familial Cancer . 2001;1:57–60
  28. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute workshop on microsatellite Instability for cancer detection and familial predisposition (development of international criteria for the determination of microsatellite instability in colorectal cancer) . Cancer Res . 1998;58:5248–5257
  29. Chai SM, Zeps N, Shearwood AM, Grieu F, Charles A, Harvey J, et al. Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients . Clin Gastroenterol Hepatol . 2004;2:1017–1025
  30. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer . Gastroenterology . 2000;118:829–834
  31. de la Chapelle A , Wright F . Linkage disequilibrium mapping in isolated populations (the example of Finland revisited) . Proc Natl Acad Sci U S A . 1998;95:12416–12423
  32. Carayol J , Khlat M , Maccario J , Bonaiti-Pellie C . Hereditary non-polyposis colorectal cancer (current risks of colorectal cancer largely overestimated) . J Med Genet . 2002;39:335–339
  33. Peltomaki P , Gao X , Mecklin J-P . Genotype and phenotype in hereditary nonpolyposis colon cancer (a study of families with different vs. shared predisposing mutations) . Familial Cancer . 2001;1:9–15
  34. Nystrom-Lahti M, Kristo P, Nicolaides N, Chang S-Y, Aaltonen L, Moisio A-L, et al. Founding mutations and Alu-medicated recombination in hereditary colon cancer . Nat Med . 1995;1:1203–1206
  35. Lin KM, Shashidharan M, Thorson AG, Ternent CA, Blatchford GJ, Christensen MA, et al. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer . J Gastrointest Surg . 1998;2:67–71

 Supported by grants CA67941 and P30 CA16058 from the National Cancer Institute.

PII: S0016-5085(05)00881-4

doi: 10.1053/j.gastro.2005.05.011

Gastroenterology
Volume 129, Issue 2 , Pages 415-421 , August 2005

Article Tools

* Image Usage & Resolution